Rising Occurrence Of Genetic Disorders Fueling The Growth Of The Market Due To Advanced Parental Age And Gene Therapy Demand Is Supporting Development Across The Viral Vector Production (Research-Use) Market

Global Viral Vector Production (Research-Use) Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Viral Vector Production (Research-Use) Market Through 2030?

The viral vector production (research-use) market has shown rapid expansion in recent years. It is anticipated to grow from $1.77 billion in 2025 to $2.04 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.2%. This historical growth can be attributed to several factors, including increased investment in gene therapy research, the expansion of academic and translational research programs, the availability of advanced cell culture technologies, the rising use of viral vectors in oncology studies, and the growth of contract research activities.

The viral vector production (research-use) market is poised for significant expansion in the coming years, projected to reach a valuation of $3.56 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 14.9%. This anticipated growth throughout the forecast period stems from several key factors, including the escalating demand for advanced gene delivery tools, increased integration of automation within research laboratories, the broadening scope of CRISPR and gene editing research, stronger partnerships between academic institutions and biopharmaceutical companies, and a heightened emphasis on reproducibility and standardization. Concurrently, dominant trends during this period are expected to feature a greater uptake of scalable viral vector manufacturing platforms, an escalating need for high-purity research-grade vectors, the expanded deployment of suspension cell culture systems, the advancement of automated upstream and downstream processing techniques, and a sharpened focus on both vector characterization and quality control.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

What Are The Main Drivers Accelerating The Growth Of The Viral Vector Production (Research-Use) Market?

The increasing incidence of genetic disorders is anticipated to drive the expansion of the viral vector production (research-use) market moving forward. Genetic disorders are conditions or illnesses resulting from abnormalities in an individual’s deoxyribonucleic acid, which can be inherited from either parent or arise from new genetic mutations. This increase in genetic disorders is linked to rising parental age, which elevates the probability of genetic mutations being passed to offspring. The growing prevalence of genetic disorders supports the growth of viral vector production (research-use) by stimulating demand for advanced gene delivery tools essential for studying disease mechanisms and developing potential therapeutic approaches. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, Trisomy 21 (Down syndrome) occurs in about 1 in 643 births, resulting in approximately 5,713 new cases annually, and Trisomy 18 occurs in about 1 in 3,336 births, or roughly 1,101 cases yearly. Therefore, the rising occurrence of genetic disorders is expected to propel the growth of the viral vector production (research-use) market.

How Does Segment Analysis Break Down The Viral Vector Production (Research-Use) Market Structure?

The viral vector production (research-use) market covered in this report is segmented –

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

What Trends Are Impacting The Viral Vector Production (Research-Use) Market?

Leading companies within the viral vector production market are prioritizing the development of advanced solutions, such as specialized cell culture media, to enhance transfection efficiency, boost viral vector yields, and ensure consistent quality for research applications. Cell culture media are nutrient-rich solutions formulated to support cell growth and maintenance outside their native environment, containing essential components like amino acids, vitamins, and growth factors optimized for specific cell types and applications. For instance, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences company, launched BalanCD HEK293 Viral Feed, recognized as the world’s first chemically defined nutrient feed specifically optimized for HEK293 suspension cultures used in AAV viral vector manufacturing. Through this launch, the company aims to significantly increase adeno-associated virus (AAV) yields, demonstrating up to 67% improvement in viral packaging efficiency compared to basal media. The feed is designed for scalable gene therapy and biotech workflows, providing consistent performance across formats and compatibility with multiple media systems.

Which Industry Players Are Present In The Viral Vector Production (Research-Use) Market?

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.

Access The Complete Viral Vector Production (Research-Use) Market Report:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

What Is The Largest Regional Market In The Viral Vector Production (Research-Use) Market?

North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Viral Vector Production (Research-Use) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

Browse Through More Reports Similar to the Global Viral Vector Production (Research-Use) Market 2026, By The Business Research Company

Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model